Exagen Inc. (XGN) stock
Close on Nov 17, 2026Market cap $91.09MP/E –Yield –
Earnings
Exagen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Exagen's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 9, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 10, 2026before the open | $18.40M | – | -$0.25 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026before the open | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026before the open | $17.30M | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 10, 2026before the open | $16.63M | +21.8% | -$0.20 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025before the open | $17.20M | +13.9% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 5, 2025before the open | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 11, 2025before the open | $13.66M | -1.1% | -$0.20 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $12.50M | -6.7% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 5, 2024before the open | $15.10M | +7.1% | -$0.16 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024before the open | $14.40M | +28.6% | -$0.19 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 18, 2024before the open | $13.80M | +7.8% | -$0.31 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023during market hours | $13.40M | -8.8% | -$0.31 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023before the open | $14.10M | +56.7% | -$0.28 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023during market hours | $11.20M | +7.7% | -$0.44 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 20, 2023during market hours | $12.80M | +0.8% | -$0.83 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022during market hours | $14.70M | +19.5% | -$0.47 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022during market hours | $9.00M | – | -$0.78 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022during market hours | $10.40M | – | -$0.60 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 22, 2022during market hours | $12.70M | – | -$0.42 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021during market hours | $12.30M | – | -$0.42 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 9, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 11, 2021during market hours | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 16, 2021during market hours | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 10, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Exagen's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | FY2026 | $72.00M – $75.00M | $70.00M – $73.00M | Raised | Nov 10, 2026 |
| revenue guidance | FY2026 | $72.00M – $75.00M | $70.00M – $73.00M | Raised | Aug 4, 2026 |
Guidance vs results
The last range Exagen gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q1 FY2024 | Revenue | $13.00M – $13.50M | $14.40M | Above range |
| Q3 FY2023 | Revenue | $10.00M – $10.50M | $13.40M | Above range |
| Q2 FY2023 | Revenue | $10.70M – $11.20M | $14.10M | Above range |
| Q1 FY2023 | Revenue | $9.20M – $9.70M | $11.20M | Above range |
Guidance history
Every forecast Exagen put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 10, 2026 | revenue | FY2026 | $72.00M – $75.00M | Raised |
| Aug 4, 2026 | revenue guidance | FY2026 | $72.00M – $75.00M | Raised |
| May 11, 2026 | revenue | FY2026 | $70.00M – $73.00M | New |
| Mar 10, 2026 | revenue | FY2026 | $70.00M – $73.00M | New |
| Nov 4, 2025 | full-year revenue | FY2025 | $65.00M – $70.00M | New |
| Jul 29, 2025 | revenue | FY2025 | $65.00M – $70.00M | Raised |
| May 5, 2025 | revenue | FY2025 | $65.00M | New |
| Mar 11, 2025 | total revenue | Q1 FY2025 | $14.50M | New |
| Nov 12, 2024 | adjusted EBITDA loss | FY2024 | -$12.00M | Lowered |
| Nov 12, 2024 | full-year revenue | FY2024 | $55.00M – $56.00M | Lowered |
| Aug 5, 2024 | adjusted EBITDA loss | FY2024 | $12.00M | Raised |
| Aug 5, 2024 | revenue | FY2024 | $57.00M | Raised |
| May 13, 2024 | adjusted EBITDA | FY2024 | -$18.00M | Raised |
| May 13, 2024 | revenue | FY2024 | $55.00M | New |
| Mar 18, 2024 | adjusted EBITDA | FY2024 | -$20.00M | New |
| Mar 18, 2024 | revenue | FY2024 | $54.00M | New |
| Mar 18, 2024 | revenue | Q1 FY2024 | $13.00M – $13.50M | New |
| Jan 8, 2024 | adjusted EBITDA | FY2023 | -$20.00M | Reaffirmed |
| Jan 8, 2024 | total revenue | FY2023 | $50.00M | New |
| Nov 13, 2023 | adjusted EBITDA | FY2023 | -$20.00M | New |
| Nov 13, 2023 | revenue | FY2023 | $50.00M | New |
| Aug 7, 2023 | revenue | Q3 FY2023 | $10.00M – $10.50M | New |
| May 15, 2023 | revenue | Q2 FY2023 | $10.70M – $11.20M | New |
| Mar 20, 2023 | guidance | Q1 FY2023 | $9.20M – $9.70M | New |
| Nov 14, 2022 | revenue | FY2022 | $40.00M – $43.00M | Raised |
| Aug 4, 2022 | revenue | FY2022 | $35.00M – $40.00M | Lowered |
| May 11, 2022 | revenue | FY2022 | $53.00M – $55.00M | Raised |
| Mar 22, 2022 | revenue | FY2022 | $51.00M – $53.00M | New |
| Nov 10, 2021 | revenue | FY2021 | $47.00M – $49.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Exagen filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- News
- News
- Results
- Update
- Results
- Results
See a number that looks wrong?